Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
Sponsor: New York State Psychiatric Institute
Listed as NCT03679949, this PHASE1 trial focuses on Abuse, Drug and Pain and remains completed. Sponsored by New York State Psychiatric Institute, it has been updated 14 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Jan 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Jan 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Sep 2023 — Jun 2024 [monthly]
Active Not Recruiting PHASE1
▶ Show 9 earlier versions
-
Jan 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting PHASE1
-
Oct 2021 — Sep 2022 [monthly]
Recruiting PHASE1
-
May 2021 — Oct 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE1
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jun 2019 — May 2020 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE1
-
Oct 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- New York State Psychiatric Institute
For direct contact, visit the study record on ClinicalTrials.gov .